News
Nueva píldora contra obesidad de Novo Nordisk, Amycretin, supera a Wegovy en un ensayo inicial
La esperadísima nueva píldora contra la obesidad muestra un potencial para una mayor y más rápida pérdida de peso que Wegovy.
![[Imagen original: Production Perig/Adobe Stock]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/03/31091922/image-3.webp)
![[Imagen: Freepik]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/04/01120818/p-91505370-How-to-deal-with-a-passive-aggressive-colleague.webp)
![[Imagen de origen: Adobe Stock]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/04/01110925/p-91518259-AI-and-purpose.webp)
![[Imágenes: Vchalup/Adobe Stock; Klyaksun/Adobe Stock]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/04/01125632/p-1-91518552-ultralightweight-sonar-plus-ai-lets-tiny-drones-navigate-like-bats.webp)
